Literature DB >> 27022573

HEMIPELVECTOMY: ERASTO GAERTNER HOSPITAL'S EXPERIENCES WITH 32 CASES IN 10 YEARS.

Rosyane Rena de Freitas1, André Luiz Soares Crivellaro1, Glauco José Pauka Mello2, Múrio Armani Neto2, Geraldo de Freitas Filho2, Letícia Viani da Silva3.   

Abstract

OBJECTIVE: To show the experience of the Erasto Gaertner Hospital with hemipelvectomy surgery over a 10-year period.
METHODS: This was a retrospective study on 32 patients who underwent hemipelvectomy at Erasto Gaertner Hospital between 1998 and 2008, assessing clinical and surgical characteristics.
RESULTS: Among the 32 patients, 15 were female and 17 were male. The mean age was 37.94 years. Eight cases showed involvement of the neurovascular bundle: three were located in the iliac and extended to the thigh, two were in the acetabulum and extended to the thigh and three were in the acetabulum and pubis. Twenty-three cases presented a neurovascular bundle free from neoplasia: 11 were restricted to the iliac, six were in the acetabular region, two were in the pubic ramus and four extended to the whole hemipelvis bone. One case involved the iliac-femoral vessels: one in the pubic ramus. Seven cases of chondrosarcoma and four cases of Ewing's sarcoma represented the majority. Eight cases underwent external hemipelvectomy and 24 underwent internal hemipelvectomy (11 were type I; four were type II; two were type II + III; three were type III and four were type IV). Of these 24 cases, 13 did not have any reconstruction, 10 had a fibular graft and one had an iliacfemoral vein and artery prosthesis. Twenty-six surgeries were curative and six were palliative. There were 14 deaths. Survival of two and five years was seen in 11 and 10 cases, respectively. For six cases, less than two years had passed since the operation. Three cases were lost during follow-up.
CONCLUSION: This study shows the experiences of an oncology reference service specializing in highly complex surgical treatment.

Entities:  

Keywords:  Hemipelvectomy; Pelvic neoplasms; Pelvis

Year:  2015        PMID: 27022573      PMCID: PMC4799085          DOI: 10.1016/S2255-4971(15)30390-6

Source DB:  PubMed          Journal:  Rev Bras Ortop        ISSN: 2255-4971


INTRODUCTION

The bones of the pelvic region are the site for less than 5% of all malignant bone tumors. Despite this rarity, they constitute a separate chapter regarding bone tumor treatment because of the e anatomical complexity of this region. They therefore remain a problem that is difficult to solve, even today1, 2. External hemipelvectomy (resection of entire hemipelvis, including the lower limb) is especially indicated for patients with extensive tumors that compromise the hemipelvis with involvement of the root of the thigh. However, with the development of new chemotherapy drugs, radiotherapy, diagnostic methods and surgical techniques, increasing numbers of patients have been undergoing limb-preserving surgery (internal hemipelvectomy)1, 2, 3, 4. Provided that a good oncological resection margin is possible without amputation, preserving surgery is indicated with the aim of obtaining oncological results similar to those obtained through external hemipelvectomy. Occasionally, hemipelvectomy with palliative intent is performed with the aim of providing local control when other, less aggressive therapeutic methods that were indicated earlier, such as radiotherapy, chemotherapy, antibiotics and powerful analgesics, among others, have not given rise to the desired effect. The aim of the present study was to show the experience of Erasto Gaertner Hospital, in Curitiba, with pelvic belt surgery between 1998 and 2008.

PATIENTS AND METHODS

Thirty-two patients who underwent hemipelvectomy at Erasto Gaertner Hospital, in Curitiba, between 1998 and 2008, were retrospectively studied, and their clinical and surgical characteristics were assessed.

RESULTS

Among the 32 patients, the minimum age was nine years, the maximum was 73 and the mean was 37.94 years. Fifteen cases were females and 17 were males. Eight cases presented tumor invasion of the neurovascular bundle: three were located in the iliac and extended to the thigh, two were in the acetabulum and extended to the thigh and three were in the acetabulum and pubis (Figure 1). Twenty-three cases did not present any tumor invasion of the neurovascular bundle: 11 were restricted to the iliac, six were in the acetabular region, two were in the pubic ramus and four extended to the whole hemipelvis bone (Figure 2). One patient presented a tumor in the region of the pubic ramus that compromised the femoral artery and vein without neural involvement.
Figure 1

Locations of the tumors with neurovascular bundle involvement

Figure 2

Locations of the tumors without neurovascular bundle involvement

Among the 24 cases that underwent internal hemipelvectomy, 13 (54%) did not undergo reconstruction, 10 (42%) underwent insertion of a fibular graft and one case (4%) required a graft consisting of an iliac-femoral vein and artery prosthesis. Among the 10 cases with a fibular graft, four underwent hemipelvectomy type IV, The smallest tumor diameter was 8 cm and the maximum was 30 cm, with a mean of 16.13 cm. With regard to histological type, the largest number (seven cases) consisted of chondrosarcoma, while Ewing's sarcoma was in second place (four cases). The other histological types are described in Box 1.
Box 1

Histopathology

Histological typeN
Adenocarcinoma2
Squamous cell carcinoma1
Chondrosarcoma7
Malignant fibrohistiocytoma3
Hemangiosarcoma1
Osteosarcoma3
PNET2
Alveolar rhabdomyosarcoma1
Embryonic rhabdomyosarcoma1
Ewing's sarcoma4
Pleomorphic and spindle cell sarcoma2
Synovial sarcoma3
Giant cell tumor2
Total32
Among the 32 patients, eight cases (25.1%) underwent external hemipelvectomy: six with reconstruction using a posterior gluteal flap and two with an anterior myocutaneous flap from the thigh (Figures 3 and 4).
Figure 3

Type of hemipelvectomy

Figure 4

Type of reconstruction in cases of external hemipelvectomy

Twenty-four cases (75%) underwent internal hemipelvectomy, distributed thus according to the Enneking classification: 11 type I, four type II, two type II + III, three type III and four type IV (Figure 5). two type II + III and four type II (Figure 6).
Figure 5

Type of internal hemipelvectomy

Figure 6

Reconstruction in cases of internal hemipelvectomy

The patient who underwent the graft of iliac-femoral vessels presented tumor formation with direct infiltration of the iliac-femoral vein and artery, without nerve involvement, and underwent hemipelvectomy type III with en-bloc resection of these vessels together with the tumor and reconstruction using PTFE prostheses for the vein and artery. Out of the 32 patients, 26 cases (81.3%) were operated with curative intent and six (18.8%) with palliative intent (Figure 7).
Figure 7

Intention: curative versus palliative

In 24 cases (75%), the surgery did not present complications. In five cases (15.6%), there was infection of the operative wound; in two (6%), hematoma; and in one (3.1%), partial necrosis of the graft (Figure 8).
Figure 8

Complications

In the present study, no local recurrence was observed. The rate of distant recurrence was 21.8% (Box 2).
Box 2

Deaths among patients with distant recurrence

One case six months laterLUNG - Death one year later
One case five years laterLUNG - Death five years later
Two cases one year laterLUNG - One lost from follow-up; the other died two years later
One case seven months laterLUNG - Death one year later
One case two months laterSPINE - Death three months later
One case four months laterSPINE - Death five months later
With regard to the surgical margins, 12.5% presented margins that were microscopically compromised (R1 resection). All these cases underwent adjuvant treatment with radiotherapy and chemotherapy, without undergoing a new surgical intervention. The types of hemipelvectomy, survival and histological types of these tumors are specified in Box 3.
Box 3

Types of hemipelvectomy, survival and histological type of the tumors with R1 resection

One caseType I internal hemipelvectomyDeath one year laterEwing's sarcoma
One caseType IV internal hemipelvectomyDeath five months laterChondrosarcoma
One caseType I internal hemipelvectomyLost from follow-up eight years laterChondrosarcoma
One caseType I internal hemipelvectomySurgery two months laterMalignant fibrohistiocytoma

Rev Bras Ortop. 2010;45(4):413-9

Over the period studied, there were 14 cases (44%) of death and three cases (9%) of loss from the followup (Figure 9). The minimum length of survival was one day, the maximum was five years and the mean was 10.6 months. Among these 14 deaths, four were patients who had undergone palliative surgery, and they died as a direct consequence of the disease (Box 4). The other 10 patients died due to causes unrelated to the surgical intervention, and none of the reported surgical complications had any impact on the patients' survival.
Figure 9

Death

Box 4

Survival among patients who underwent palliative hemipelvectomy

One caseOne day
One caseTwo months
One caseThree months
One caseFive months
Two casesLost from follow-up
Two years of survival was observed in 11 cases (34.4%), six cases (18.8%) had had recent surgery (less than two years of follow-up) and three cases (9.4%) were lost from the follow-up (Figure 10). None of the cases with distant recurrence survived for two years.
Figure 10

Two-year survival

With regard to the functional point of view of the patients who underwent hemipelvectomy, the 15 surviving cases were interviewed recently for the present study, in order to ascertain their satisfaction with the surgery. The final result was based on the functional staging according to Enneking, as adopted by the Musculoskeletal Tumor Society. This classification is as follows: Excellent: no pain, functions without restrictions, and excellent acceptance by the patient; Good: low-intensity non-incapacitating pain and/or restrictions on recreation functions, and good acceptance by the patient; Regular: moderate pain with intermittent incapacitation and/or partial occupational restriction, and regular acceptance by the patient; Poor: high-intensity pain with continuous incapacitation, and/or total occupational restriction, and patient dissatisfaction. The data obtained are shown in Figure 12.
Figure 12

Overall functional result, in accordance with the categories of the classification of Enneking et al (1993), among patients who underwent hemipelvectomy

Figure 13, Figure 14 and 15 show, respectively: the time of the surgery, with reconstruction using the fibula in type IV internal hemipelvectomy; vascular reconstruction of the iliac-femoral vein and artery, in internal hemipelvectomy; and the final appearance of the lower limbs of the patient who underwent vascular reconstruction.
Figure 13

Reconstruction using fibula in case of type IV internal hemipelvectomy

Figure 14

Vascular reconstruction of iliac-femoral vein and artery in case of internal hemipelvectomy

Figure 15

Final appearance of lower limbs of patient who underwent vascular reconstruction

Five years of survival was observed in 10 cases (31.3%), six cases (18.8%) had had recent surgery (less than five years of follow-up) and three cases (9.4%) were lost from the follow-up (Figure 11). None of the cases with distant recurrence survived for five years.
Figure 11

Five-year survival

DISCUSSION

Despite all the development of oncological surgery, resection of pelvic tumors is one of the problems that have undergone most changes in limb-preserving surgery. The malignant tumors most commonly encountered in the pelvic region are, in order of frequency, chondrosarcoma, Ewing's sarcoma and osteosarcoma. In our study, the majority consisted of chondrosarcoma and, in second place, Ewing's sarcoma; these data agree with the literature. The type of surgery (external or internal hemipelvectomy) is based on the size of the tumor and/or the lo-cation of the adjacent structures and tissues involved. Extensive tumors of the pelvic region that invade bones, soft tissues, nerves and vessels are difficult to treat conservatively. External hemipelvectomy is a procedure with considerable morbidity and is today only indicated for a small proportion of pelvic tumors, when the extent of the tumor and the involvement of the root of the thigh and the neurovascular bundle make it impossible to preserve the limb. In such cases, it may be the only alternative for resection of these tumors with adequate margins and an acceptable disease-free interval. In a standard external hemipelvectomy procedure, a gluteal myocutaneous flap is the reconstruction most used. For extensive gluteal tumors or tumors of the posterior proximal region of the thigh that require hemipelvectomy for treatment, an anterior myocutaneous flap from the thigh, maintained using femoral veins, is without doubt the most appropriate and safest option6, 7. In our study, out of the 32 patients, eight (25.1%) underwent external hemipelvectomy (six with a gluteal flap and two with an anterior myocutaneous flap from the thigh). Internal hemipelvectomy is a complex procedure but cosmetically superior to external hemipelvectomy. It is indicated for smaller tumors that are restricted to the hemipelvis, without compromising the thigh and without neurovascular invasion of the iliofemoral bundle. In cases in which there is vascular invasion, without neural involvement, surgery may be indicated with re-construction of the artery and/or vein with a vascular prosthesis, in order to keep the ipsilateral lower limb functional. In our study, one of the cases underwent associated vascular reconstruction. The type of internal hemipelvectomy according to the Enneking classification is based on the location of the tumor in the pelvis: type I (wing of the iliac), type II (periacetabular region), type III (pubic arch) and type IV (entire bone of the hemipelvis). In our study, 24 cases (75%) underwent internal hemipelvectomy: 11 cases of type I, two of type II + III, four of type II, three of type III and four of type IV. One point that remains controversial in the literature is the question of reconstruction in cases of internal hemipelvectomy. In a study retrospectively evaluating 31 cases (12 at the AC Camargo Hospital in Sao Paulo and 19 at the Boldrini Hospital in Campinas) that underwent type II hemipelvectomy, with or without reconstruction of the pelvic ring using the fibula, the patients who underwent internal hemipelvectomy with reconstruction of the pelvic ring using an autograft from the fibula had better overall functional results than shown by the group that did not undergo reconstruction (p = 0.007). In our study, out of the 24 cases that underwent internal hemipelvectomy, 10 (42%) received a fibular graft: four type IV, two type II + III and four type II. No comparative functional study between the two groups was made at our service. In the literature, two non-consensual strands can be seen in relation to indications for pelvic reconstruction after internal hemipelvectomy: Surgeons who have not indicated pelvic reconstruction have emphasized the difficulty in making surgical approaches to the pelvis, because of the proximity to organs and neurovascular bundles. Guest et al mentioned that reconstruction of the acetabulum was as difficult as the removal of the tumor. Veth et al emphasized the fact that after resection of the pelvic tumor, the hip and lower-limb function would never be normal, independent of the reconstruction performed. These authors published satisfactory functional results from patients without reconstruction. Another point considered by Hugate and Sim was the duration of the operation and the blood loss, which are less in operations without reconstruction. It is important to note that, for patients who undergo type I resection (iliac wing lesions) or type III resection (lesions in the ischiopubic region), reconstruction is not necessary because the biomechanical change that is caused does not lead to any considerable functional loss. Surgeons who advocate reconstruction justify this in terms of the possibility of restoring pelvic stability, maintaining hip mobility, minimizing the discrepancy in leg length and, consequently, obtaining better functional and esthetic results13, 14. Nevertheless, there is still no consensus regarding whether or not to reconstruct the pelvis after tumor resection. It has not been defined which type of surgery would bring greatest benefit to patients. Several studies have been conducted over recent decades, and each of them has presented advantages and disadvantages of a variety of surgical techniques relating to resection of pelvic tumors. Certain other points also remain controversial. The first of these is postoperative disease control and survival. Studies have shown that after resection consisting of hemipelvectomy for high-grade sarcomas, the survival rate has ranged up to 40%, with local recurrence of 70%8, 15. In our study, considering the different histological types, the mean length of survival was 10.6 months, and the two and five-year survival rates were 34.4% and 31.3%, respectively. Local recurrence, which is one of the main complications, with an important impact on survival, was not observed in our study. The second point concerns the high complication rate reported in relation to these extensive and complex surgical procedures. Among the most common of these complications are superficial and deep infections, seroma, suture dehiscence, loosening of fibular grafts, neuropraxia and venous thrombosis. Infections and nerve lesions, among others, can reach incidence of 50%5, 8, 16. In our study, there were no complications in 75% of the patients, while superficial infection of the operative wound occurred in 15.6%, superficial subcutaneous hematomas in 6% and partial graft necrosis in 3.1%. None of these complications required a new surgical intervention, and they were treated using antibiotic therapy, outpatient drainage of the superficial hematoma in the operative wound and debridement of the edges of the operative wound, respectively. No cases of loosening of fibular grafts, severe neuropraxia, thrombosis or other, more severe complications were observed. Palliative hemipelvectomy has been indicated for patients with metastatic or locally advanced bone disease17, 18. The indications include intractable pain, ulceration, hemorrhage, infection and unstable pathological fracture; however, there is still no consensus in the literature regarding this indication. Because palliative hemipelvectomy is controversial, especially in cases with less than one year of survival, it is of utmost importance to evaluate other options before surgery17, 18. In our study, six patients were operated with palliative intent. Among these, the survival was one, 60, 90 and 180 days among the patients who continued with the follow-up, while two cases were lost from the followup and their survival could therefore not be determined. The final analysis on the improvement of quality of life achieved through the surgery was not quantified through standardized questionnaires. Thus, because of the retrospective design of this study, we were unable to come to conclusions regarding the results attained through the palliative indication. Nonetheless, it is worth emphasizing that the indications were based on the patients' symptoms of worsening pain, infection and local bleeding that were unresponsive to drug treatment and radiotherapy, with a desire to undergo surgery mentioned by the patient, who was made aware of the impossibility of a cure and the extend of the procedure. With regard to the functional results, in several cases they have been good and encouraging, even allowing some patients to walk without the aid of crutches or sticks and allowing single-leg loading of body weight. Some patients have required several months for rehabilitation but have achieved the possibility of walking without crutches, while others have been able to walk
  16 in total

1.  An examination of outcome measures to assess functional mobility in childhood survivors of osteosarcoma.

Authors:  Victoria G Marchese; Susan Ogle; Richard B Womer; John Dormans; Jill P Ginsberg
Journal:  Pediatr Blood Cancer       Date:  2004-01       Impact factor: 3.167

2.  Pelvic resections: the Rizzoli Institute experience.

Authors:  M Campanacci; R Capanna
Journal:  Orthop Clin North Am       Date:  1991-01       Impact factor: 2.472

3.  Complications and outcome of external hemipelvectomy in the management of pelvic tumors.

Authors:  J P Apffelstaedt; D L Driscoll; J E Spellman; A F Velez; J F Gibbs; C P Karakousis
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

4.  The saddle prosthesis in pelvic primary and secondary musculoskeletal tumors: functional results at several postoperative intervals.

Authors:  A J Renard; R P Veth; H W Schreuder; M Pruszczynski; A Keller; Q van Hoesel; J P Bökkerink
Journal:  Arch Orthop Trauma Surg       Date:  2000       Impact factor: 3.067

5.  Variants of hemipelvectomy and their complications.

Authors:  C P Karakousis; L J Emrich; D L Driscoll
Journal:  Am J Surg       Date:  1989-11       Impact factor: 2.565

Review 6.  A critique of techniques for reconstruction after internal hemipelvectomy for osteosarcoma.

Authors:  R P Veth; H Schraffordt Koops; H K Nielsen; J Oldhoff; G J Verkerke; A Postma
Journal:  Cancer Treat Res       Date:  1993

7.  Allograft-implant composite reconstruction following periacetabular sarcoma resection.

Authors:  C B Guest; R S Bell; A Davis; F Langer; H Ling; A E Gross; A Czitrom
Journal:  J Arthroplasty       Date:  1990       Impact factor: 4.757

Review 8.  Chondrosarcoma of the pelvis. A review of sixty-four cases.

Authors:  M E Pring; K L Weber; K K Unni; F H Sim
Journal:  J Bone Joint Surg Am       Date:  2001-11       Impact factor: 5.284

9.  Resection of the pubic bone as an adjunct to management of primary, recurrent, and metastatic pelvic malignancies.

Authors:  L A King; G O Downey; J E Savage; L B Twiggs; G J Oakley; K A Prem
Journal:  Obstet Gynecol       Date:  1989-06       Impact factor: 7.661

10.  Resection and reconstruction for primary neoplasms involving the innominate bone.

Authors:  W F Enneking; W K Dunham
Journal:  J Bone Joint Surg Am       Date:  1978-09       Impact factor: 5.284

View more
  3 in total

Review 1.  Outcomes of internal hemipelvectomy for pelvic tumors: a developing country's prospective.

Authors:  Masood Umer; Moiz Ali; Rizwan H Rashid; Yasir Mohib; Haroon U Rashid
Journal:  Int J Surg Oncol (N Y)       Date:  2017-04-18

2.  Three-dimensional-printed customized prosthesis for pubic defect: prosthesis design and surgical techniques.

Authors:  Yuqi Zhang; Li Min; Minxun Lu; Jie Wang; Yitian Wang; Yi Luo; Yong Zhou; Hong Duan; Chongqi Tu
Journal:  J Orthop Surg Res       Date:  2020-07-13       Impact factor: 2.359

3.  External and internal hemipelvectomy: A retrospective analysis of 68 cases.

Authors:  Mustafa Onur Karaca; Emre Anıl Özbek; Mustafa Özyıldıran; Abdullah Merter; Kerem Başarır; Hüseyin Yusuf Yıldız; Yener Sağlık
Journal:  Jt Dis Relat Surg       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.